These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38866185)

  • 1. Circulating asprosin concentrations in individuals with new-onset type 2 diabetes and prediabetes.
    Diao H; Fan X; Li Z; Hou L; Dong Z; Pang S
    Diabetes Res Clin Pract; 2024 Jul; 213():111730. PubMed ID: 38866185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
    Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
    Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
    Wang Y; Qu H; Xiong X; Qiu Y; Liao Y; Chen Y; Zheng Y; Zheng H
    Mediators Inflamm; 2018; 2018():9471583. PubMed ID: 29743813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin.
    Gozel N; Kilinc F
    Endokrynol Pol; 2021; 72(1):37-43. PubMed ID: 32944923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus.
    Zhang X; Jiang H; Ma X; Wu H
    J Diabetes Investig; 2020 Mar; 11(2):349-355. PubMed ID: 31529619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress and Asprosin Levels in Type 2 Diabetic Patients with Good and Poor Glycemic Control.
    Senyigit A; Durmus S; Gelisgen R; Uzun H
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334889
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating mesencephalic astrocyte-derived neurotrophic factor is increased in newly diagnosed prediabetic and diabetic patients, and is associated with insulin resistance.
    Wu T; Zhang F; Yang Q; Zhang Y; Liu Q; Jiang W; Cao H; Li D; Xie S; Tong N; He J
    Endocr J; 2017 Apr; 64(4):403-410. PubMed ID: 28216543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance.
    Wang K; Li F; Wang C; Deng Y; Cao Z; Cui Y; Xu K; Ln P; Sun Y
    Med Sci Monit; 2019 Mar; 25():2337-2343. PubMed ID: 30928991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
    Zhang L; Chen C; Zhou N; Fu Y; Cheng X
    Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus.
    Dai C; Zhu W
    Medicine (Baltimore); 2022 Oct; 101(43):e31334. PubMed ID: 36316938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
    Zhang H; Hu W; Zhang G
    Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asprosin serum levels and glucose homeostasis in children with obesity.
    Corica D; Aversa T; Currò M; Tropeano A; Pepe G; Alibrandi A; Ientile R; Wasniewska M
    Cytokine; 2021 Jun; 142():155477. PubMed ID: 33662891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.
    Zhong M; Tian X; Sun Q; Li L; Lu Y; Feng Z; Gao Y; Li S
    BMC Endocr Disord; 2023 Mar; 23(1):61. PubMed ID: 36915073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of asprosin in new-onset type 2 diabetes.
    Naiemian S; Naeemipour M; Zarei M; Lari Najafi M; Gohari A; Behroozikhah MR; Heydari H; Miri M
    Diabetol Metab Syndr; 2020; 12():65. PubMed ID: 32714446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus.
    Zheng X; Ren W; Zhang S; Liu J; Li S; Li J; Yang P; He J; Su S; Li P
    Acta Diabetol; 2010 Sep; 47(3):265-70. PubMed ID: 20509034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research).
    Yang G; Li C; Gong Y; Fang F; Tian H; Li J; Cheng X
    J Diabetes Res; 2016; 2016():9270768. PubMed ID: 26770991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meal-Related Asprosin Serum Levels Are Affected by Insulin Resistance and Impaired Fasting Glucose in Children With Obesity.
    Corica D; Pepe G; Aversa T; Currò M; Curatola S; Li Pomi A; Alibrandi A; Ientile R; Wasniewska M
    Front Endocrinol (Lausanne); 2021; 12():805700. PubMed ID: 35069452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Serum ANGPTL8 Concentrations in Patients with Prediabetes and Type 2 Diabetes.
    Yin Y; Ding X; Peng L; Hou Y; Ling Y; Gu M; Wang Y; Peng Y; Sun H
    J Diabetes Res; 2017; 2017():8293207. PubMed ID: 29082263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances.
    Nedeva IS; Assyov Y; Karamfilova V; Vodenicharov V; Gerganova A; Hristova J; Kamenov Z
    Horm Metab Res; 2023 Apr; 55(4):284-289. PubMed ID: 36773601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.